Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[New developments in labor induction].

Vered Yulzari-Roll, Moshe Hod, Jacob Bar

    Harefuah
    |May 23, 2002
    PubMed
    Summary
    This summary is machine-generated.

    Misoprostol is an effective medication for labor induction and cervical ripening. Careful patient selection and dosage adjustments can mitigate risks like uterine hyperstimulation.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The FemTech revolution: Unlocking the potential of new technology for optimizing pregnancy outcomes in low- and middle-income countries and remote areas.

    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2026
    Same author

    The Contribution of Ultrasound and Doppler Studies on Impaired Intrauterine Conditions and the Development of Future Disease.

    Medicina (Kaunas, Lithuania)·2026
    Same author

    Early pregnancy is characterized by a significant decrease in the diversity of the oral microbiome and strong associations with lifestyle and conception method.

    Journal of oral microbiology·2026
    Same author

    Managing maternity: Moving care, not patients, using artificial intelligence (AI), internet-of-things (IOT) and point-of-care testing (POCT) devices.

    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2026
    Same author

    The association of gestational weight gain with carotid intima-media thickness in correlation with pregnancy outcome and placental assessment: a prospective study.

    Minerva obstetrics and gynecology·2026
    Same author

    Artificial intelligence for personalized multiple micronutrient supplementation in maternal health.

    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2026
    Same journal

    [Tennis Elbow Among Players].

    Harefuah·2026
    Same journal

    [Internal Medicine - My Mission].

    Harefuah·2026
    Same journal

    [Treatment of Morbid Obesity in Israel: GLP-1 Agonists Versus Bariatric Surgery - Clinical and Economic Aspects].

    Harefuah·2026
    Same journal

    [Baby steps: Post-operative Treatment Recommendations for Pediatric Tracheostomy in Israel].

    Harefuah·2026
    Same journal

    [Mastoiditis Caused by Fusobacterium Necrophorum: an Unusual Pathogen in a Well-Known Disease].

    Harefuah·2026
    Same journal

    [Cochlear Implantation in Single-Sided Deafness - Six Years of Follow-Up from Diagnosis and Consistent Use, Through Dedicated and Creative Auditory Learning, to the Development of Bilateral Central Processing Abilities].

    Harefuah·2026
    See all related articles

    Area of Science:

    • Obstetrics and Gynecology
    • Pharmacology

    Context:

    • Misoprostol, a prostaglandin E1 analogue, has been evaluated for labor induction and cervical ripening over the past eight years.
    • This review synthesizes findings from 33 articles published between 1993 and 2001.

    Purpose:

    • To review the existing literature on the efficacy, safety, and optimal dosage of misoprostol for labor induction.
    • To assess misoprostol's role in modern obstetric practice.

    Summary:

    • Misoprostol demonstrates high efficacy in labor induction compared to other agents like oxytocin.
    • While effective and cost-efficient, misoprostol can increase uterine activity (tachysystole, hyperstimulation), necessitating careful patient selection and dose management.
    • Potential risks such as uterine rupture can be managed through safety measures like dose reduction and extended dosing intervals.

    Related Experiment Videos

    Impact:

    • Misoprostol is a valuable and efficient obstetric medication for cervical ripening and labor induction.
    • Findings support the continued use and further clinical investigation of misoprostol in obstetrics.
    • Recommendations for safe clinical application are provided, including dose titration and patient monitoring.